GSK Sues Moderna Over mRNA Patents
This is a news story, published by Yahoo Finance, that relates primarily to Moderna news.
Moderna news
For more Moderna news, you can click here:
more Moderna newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
several GSK patents. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest mRNA vaccine portfolio news, mRNA technology news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
patentsReuters
•GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
77% Informative
GlaxoSmithKline accuses Moderna of violating GSK 's patent rights in messenger RNA (mRNA) technology with its vaccine Spikevax .
GSK filed a related lawsuit against Pfizer and BioNTech in the same court in April over their COVID-19 vaccine.
Moderna earned $6.7 billion in revenue last year from SpikeVax .
A GSK spokesperson said the drugmaker is "willing to license these patents on commercially reasonable terms".
VR Score
87
Informative language
96
Neutral language
9
Article tone
formal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links